Understanding SURPASS-ET: What the New Ropeginterferon Data Mean for Essential Thrombocythemia
The FDA Approval of essential thrombocythemia (ET) continues to evolve as researchers investigate therapies that can address both blood-count control...
The FDA Approval of essential thrombocythemia (ET) continues to evolve as researchers investigate therapies that can address both blood-count control...
